These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6572536)

  • 1. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Blood; 1983 May; 61(5):935-9. PubMed ID: 6572536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomes and causation of human cancer and leukemia. IL. Therapeutic and prognostic value of chromosomal findings during acute phase in Ph1-positive chronic myeloid leukemia.
    Sadamori N; Gomez GA; Sandberg AA
    Hematol Oncol; 1983; 1(1):77-83. PubMed ID: 6588019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome changes and splenectomy in Ph1-positive CML. II. Prognostic aspects in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1984 Aug; 12(4):303-8. PubMed ID: 6589034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and prognostic value of chromosomal AP classification at the blastic phase of Ph-positive chronic myeloid leukemia: comparison of data from Nagasaki University, Japan and Roswell Park Memorial Institute, U.S.A.
    Sadamori N; Yao E; Mine M; Tokunaga S; Matsunaga M; Nakamura H; Sasagawa I; Itoyama T; Kawachi T; Sandberg AA
    Leuk Lymphoma; 1991; 5(2-3):187-92. PubMed ID: 21269080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomes and causation of human cancer and leukemia: XXXIX. Usual and unusual findings in Ph1-positive CML.
    Kohno SI; Sandberg AA
    Cancer; 1980 Nov; 46(10):2227-37. PubMed ID: 6932994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML.
    Sonta S; Sandberg AA
    Cancer; 1978 Jan; 41(1):153-63. PubMed ID: 272225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome abnormalities in chronic myeloid leukemia in children.
    Puchkova GP; Prigogina EL; Fleischmann EW; Drosdova TS; Mayakova SA; Peterson IS
    Hum Genet; 1983; 64(3):257-62. PubMed ID: 6576982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal evolution with isodicentric Ph1 chromosome in Ph1-positive CML: karyotypic conversion after bone marrow transplantation.
    Becher R; Ohl S; Schaefer UW; Wendehorst E; Quiskamp F; Mahmoud HK; Schüning F; Schmidt CG
    Blut; 1984 Apr; 48(4):247-50. PubMed ID: 6370340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome changes and splenectomy in Ph-positive CML. III. Predictive parameters in the chronic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):227-34. PubMed ID: 3855366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases.
    Alimena G; Dallapiccola B; Gastaldi R; Mandelli F; Brandt L; Mitelman F; Nilsson PG
    Scand J Haematol; 1982 Feb; 28(2):103-17. PubMed ID: 6953563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clones with 3 Ph1 and 4 Ph1 in the terminal phase of three cases of chronic myeloid leukemia.
    Cabrol C; Peytremann R; Maurice PA
    Acta Haematol; 1982; 67(3):150-9. PubMed ID: 6805200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia presenting in the blastic phase and its association with a 45 XO Ph1 karyotype.
    Nigam R; Dosik H
    Blood; 1976 Feb; 47(2):223-7. PubMed ID: 1060474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.
    Oshimura M; Ohyashiki K; Terada H; Takaku F; Tonomura A
    Cancer Genet Cytogenet; 1982 Mar; 5(3):187-201. PubMed ID: 6950809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cell clones in bone marrow and spleen of a patient with chronic myelocytic leukemia (CML) in blastic phase.
    Olinici CD; Petrov L; Macavei I; Dobay O
    Cancer; 1978 Dec; 42(6):2707-9. PubMed ID: 282004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia.
    Sakurai M; Hayata I; Sandberg AA
    Cancer Res; 1976 Feb; 36(2 Pt 1):313-8. PubMed ID: 1063061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of chromosomal findings in the blast phase of Ph1-positive chronic myeloid leukaemia (CML).
    Oláh E; Rák K
    Int J Cancer; 1981 Mar; 27(3):287-95. PubMed ID: 6945294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patho-anatomical features of so-called Ph1- chronic myeloid leukemia.
    Schwarze EW; Schwalbe P; Klein UE
    Virchows Arch A Pathol Anat Histol; 1975 Jul; 367(2):137-48. PubMed ID: 808893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth pattern and SCE incidence in Ph1-positive cells of CML.
    Abe S; Kakati S; Sandberg AA
    Cytobios; 1980; 28(111-112):137-49. PubMed ID: 6938334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.